Correction: BMC Med 21, 294 (2023)
https://doi.org/10.1186/s12916-023-02990-9
Following the publication of the original article it was brought to our attention that the published version of the manuscript retained reference to “deep learning” where Deep learning methods where initially employed in the study following subsequent rounds of revision these techniques were removed from the study. A combination of machine learning and other statistical methodologies replaced the deep learning techniques and as such this term should be replaced throughout the manuscript.
Reference
Gao, et al. Identification of a novel bile marker clusterin and a public online prediction platform based on machine learning for cholangiocarcinoma. BMC Med. 2023;21:294. https://doi.org/10.1186/s12916-023-02990-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gao, L., Lin, Y., Yue, P. et al. Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma. BMC Med 22, 179 (2024). https://doi.org/10.1186/s12916-024-03404-0
Published:
DOI: https://doi.org/10.1186/s12916-024-03404-0